Renata Freire de Moraes, Bruno da Silva Athanasio, Karoline Carvalho Carmona, Leandro Boson Gambogi, Luís Gustavo Fraga Belotto, Elisa de Paula França Resende, Paulo Caramelli, Leonardo Cruz de Souza
{"title":"Cerebral perfusion SPECT in the diagnostic framework of degenerative dementias: still useful after all these years.","authors":"Renata Freire de Moraes, Bruno da Silva Athanasio, Karoline Carvalho Carmona, Leandro Boson Gambogi, Luís Gustavo Fraga Belotto, Elisa de Paula França Resende, Paulo Caramelli, Leonardo Cruz de Souza","doi":"10.1159/ndd/aduag010","DOIUrl":"https://doi.org/10.1159/ndd/aduag010","url":null,"abstract":"<p><strong>Introduction: </strong>The clinical distinction between the different types of dementia is a clinical challenge and establishing an accurate diagnosis is essential for guiding treatment. We aimed to investigate the diagnostic value of cerebral perfusion SPECT in the diagnostic framework of dementias.</p><p><strong>Methods: </strong>We included patients with cognitive disorders who underwent a cerebral SPECT between 2013-2019. Medical data for all participants were collected, and clinical diagnosis were established independently of the SPECT findings. All SPECT images were blindly analysed, by describing the topographical patterns of hypoperfusion.</p><p><strong>Results: </strong>We included 51 patients: typical Alzheimer's disease (AD; n=24), behavioral variant frontotemporal dementia (bvFTD, n=15), primary progressive aphasia (PPA, n=6), and atypical AD (logopenic aphasia and behavioral/dysexecutive variant AD, n=6). SPECT achieved 72% and 66% for distinguishing typical AD from bvFTD and AD (typical and atypical cases) from FTD (PPA and bvFTD), respectively. Compared to bvFTD, hypoperfusion in inferior parietal (p < 0.002), in the superior parietal (p < 0.01) and in the lateral temporal (p < 0.018) regions were more frequent in the typical AD group. Considering all AD cases (typical and atypical presentations) and FTD (PPA and bvFTD), hypoperfusion in the anterior temporal (p < 0.03) and in basal ganglia (p < 0.026) were more frequent in the FTD group. On the contrary, hypoperfusion in inferior parietal (p < 0.0001), in the superior parietal (p < 0.004) and in the lateral temporal (p < 0.03) cortex were more common in AD than in FTD patients.</p><p><strong>Conclusion: </strong>The diagnostic value of a SPECT for differentiating dementias is limited, but specific topographical patterns of hypoperfusion may be useful for distinguishing AD from bvFTD. .</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":""},"PeriodicalIF":4.0,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Structural Social Connection, Biological Ageing, and Neurodegenerative Disease Burden: A Global Ecological Analysis of Household Size and Modelled Dementia Incidence Estimates.","authors":"Wenpeng You","doi":"10.1159/ndd/aduag008","DOIUrl":"https://doi.org/10.1159/ndd/aduag008","url":null,"abstract":"<p><strong>Background: </strong>Poor social connection and ageing-related biological processes are recognised contributors to Alzheimer's disease and related dementias. However, cross-national evidence linking structural indicators of social connection with dementia and broader neurological dis-ease burden remains limited. This ecological study examined country-level associations be-tween average household size and modelled neurological disease incidence estimates.</p><p><strong>Methods: </strong>Country- and territory-level data from up to 204 settings were analysed. Average household size was the primary exposure, and model-derived, age-standardised incidence-rate estimates for Alzheimer's disease and other dementias were the primary outcome. Par-kinson's disease, motor neuron disease, multiple sclerosis, idiopathic epilepsy, headache dis-orders, and total neurological disorders were examined as comparative secondary outcomes. The Henneberg Index, life expectancy at age 60, GDP per capita, and urban living were in-cluded as contextual covariates. Analyses included Pearson and Spearman correlations, par-tial correlations, principal component analysis, and multivariable linear regression.</p><p><strong>Results: </strong>Household size was strongly and inversely associated with Alzheimer's disease and other dementias incidence estimates (Pearson r=-.841, p<.001). The association remained after adjustment for the included covariates (β=-.569, p<.001). Significant inverse adjusted associations were also observed for Parkinson's disease, motor neuron disease, and total neurological disorders, whereas patterns differed for other neurological outcomes. Principal component analysis identified a single ageing-development dimension explaining 72.1% of the variance, with household size loading inversely against life expectancy at age 60, econom-ic affluence, urban living, and the Henneberg Index.</p><p><strong>Conclusion: </strong>Smaller average household size was associated with higher modelled incidence estimates for dementia and selected neurodegenerative diseases at the country level. These findings should be interpreted as ecological associations rather than evidence of individual-level causation and suggest that household structure is embedded within broader demograph-ic, socioeconomic, and ageing-related processes.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149288027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Modification of locomotion-respiration coupling in patients with obstructive sleep apnea syndrome.","authors":"Rémi Valentin, Baptiste Sandoz, Marie-Cécile Niérat, Thomas Similowski, Valérie Attali, Hélène Pillet","doi":"10.1159/ndd/aduag007","DOIUrl":"https://doi.org/10.1159/ndd/aduag007","url":null,"abstract":"<p><strong>Introduction: </strong>Locomotion is a complex motor task integrating sensory-motor and cognitive inputs through central pattern generator control. Locomotion-respiration coupling (LRC), defined as the synchronization between gait and breathing events, has been described during running and walking. Patients with obstructive sleep apnea syndrome (OSAS) exhibit altered gait patterns during wakefulness, which appear to be partially independent of nocturnal symptomatic treatment. While intermittent hypoxia may induce long-term (\"fixed\") central nervous system alterations, OSAS patients also display \"reversible\" adaptive mechanisms during wakefulness aimed at preventing upper airway (UA) collapse, involving changes in respiratory control and posture. Whether these adaptive mechanisms affect LRC and contribute to gait alterations remains unknown.</p><p><strong>Methods: </strong>Ten awake patients with controlled OSAS treated with a mandibular advancement device (MAD) and ten matched healthy controls performed a one-minute walking trial on an instrumented treadmill with motion capture. Ventilation was assessed via thoracic expansion, and spatiotemporal gait parameters were extracted from kinematic and force platform data. LRC was quantified using phase-locking values (PLV) between ventilatory events and sagittal-plane joint kinematics. OSAS patients were assessed both with and without their MAD.</p><p><strong>Results: </strong>Compared with controls, OSAS patients exhibited a longer double-stance phase and a shorter swing phase. Expiratory events occurred preferentially during double stance in OSAS patients, whereas controls showed a higher occurrence during swing. PLV analysis revealed increased synchronization between inspiratory events and hip and knee motion, as well as between expiratory events and trunk and hip motion in OSAS patients. These significative differences were no longer observed when patients wore their MAD. Logistic regression demonstrated that PLV metrics of inspiratory-hip and expiratory-trunk coupling effectively discriminated OSAS patients from controls, but not when UA stabilization was applied.</p><p><strong>Conclusion: </strong>Awake patients with controlled OSAS exhibit altered gait patterns characterized by increased locomotion-respiration coupling. This heightened synchronization likely reflects adaptive, reversible strategies aimed at limiting UA collapsibility during wakefulness rather than fixed hypoxia-related impairments alone. LRC may represent a functional marker of daytime motor alterations in OSAS and a potential target for interventions addressing UA mechanics beyond nocturnal treatment.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149228256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Setareh Ranjbar, Ruken Yaman-Deveci, Kevin Swierkosz-Lenart, Mohamed Hichem Lakhal, Alessia Donati, Pierre Vandel, Armin von Gunten, Beatriz Pozuelo Moyano
{"title":"Early Parental Attachment Style and Late-Life Depressive Symptoms: An Exploratory Analysis on the Moderating Role of Mild Cognitive.","authors":"Setareh Ranjbar, Ruken Yaman-Deveci, Kevin Swierkosz-Lenart, Mohamed Hichem Lakhal, Alessia Donati, Pierre Vandel, Armin von Gunten, Beatriz Pozuelo Moyano","doi":"10.1159/ndd/aduag005","DOIUrl":"10.1159/ndd/aduag005","url":null,"abstract":"<p><strong>Background: </strong>Early relationships with caregivers shape emotional and cognitive development, colouring attitudes and behaviours across the lifespan. Secure attachment has consistently been associated with a lower risk of late-life depression (LLD). However, the extent to which parental (maternal or paternal) attachment contributes to late-life depressive symptoms and whether this association is influenced by cognitive impairment remains unclear.</p><p><strong>Objectives: </strong>We investigated whether mild cognitive impairment (MCI) moderates the association between parental (maternal/paternal) attachment style (secure vs. insecure) and late-life depressive symptoms.</p><p><strong>Methods: </strong>We analysed data from 120 participants enrolled in a cross-sectional study conducted at the Old-Age Psychiatric Service of Lausanne University Hospital. Retrospective parental attachment was assessed using the Attachment Multiple Model Interview (AMMI), from which maternal and paternal secure and insecure attachment scores were derived. Late-life depressive symptoms were measured with the Cornell Scale for Depression in Dementia using both self- and informant-reports. MCI was defined using the Clinical Dementia Rating (CDR), with a global score equal to 0.5 indicating MCI. Associations and potential moderation by MCI were examined using multiple linear regression models.</p><p><strong>Results: </strong>Lower secure paternal attachment was significantly associated with higher self- and informant-reported depressive symptom severity, but only among participants with MCI. No significant associations were observed independently of the MCI for maternal attachment or insecure paternal attachment.</p><p><strong>Conclusions: </strong>Early paternal bonds may shape emotional vulnerability differently in the context of cognitive decline. These results suggest considering both attachment history and cognitive status in interventions for late-life depressive symptoms.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149128077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Can Music-Induced Brain Plasticity Delay Neurodegenerative Disorders in Musicians? Review and Cases.","authors":"Eckart Altenmüller","doi":"10.1159/ndd/aduag004","DOIUrl":"10.1159/ndd/aduag004","url":null,"abstract":"<p><strong>Background: </strong>Intensive musical training induces neuroplasticity, potentially enhancing cognitive reserve and delaying neurodegenerative symptoms.</p><p><strong>Summary: </strong>This review examines music-induced brain adaptations and therapeutic interventions in dementia and Parkinson's disease (PD). Epidemiological evidence suggests reduced dementia risk among musicians, while rhythmic auditory cueing and dancing improve motor function in PD. Musical interventions may also alleviate cognitive and neuropsychiatric symptoms in dementia. The cases of Maurice Ravel and Aaron Copland illustrate musicians' continued vulnerability to neurodegeneration.</p><p><strong>Key messages: </strong>Musical engagement may enhance cognitive resilience without preventing neurodegeneration. Larger randomized controlled trials with appropriate controls and long-term follow-up are needed to establish therapeutic efficacy and disease-modifying effects.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149031296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nan Hu, Ning Su, Dingding Zhang, Jiangxia Zhang, Kai Wang, Yuming Xu, Zhenzhong Li, Lihua Wang, Bo Wu, Lan Chu, Yinzhou Wang, Hong Jiang, Zhengqi Lu, Jian Wu, Xiangmin Fan, Fei Han, Jing Yuan, Yicheng Zhu, Mingsheng Liu
{"title":"Gait Characteristics and Fall Risk in Amyotrophic Lateral Sclerosis: A 12-Month Prospective Cohort Study.","authors":"Nan Hu, Ning Su, Dingding Zhang, Jiangxia Zhang, Kai Wang, Yuming Xu, Zhenzhong Li, Lihua Wang, Bo Wu, Lan Chu, Yinzhou Wang, Hong Jiang, Zhengqi Lu, Jian Wu, Xiangmin Fan, Fei Han, Jing Yuan, Yicheng Zhu, Mingsheng Liu","doi":"10.1159/ndd/aduag003","DOIUrl":"10.1159/ndd/aduag003","url":null,"abstract":"<p><strong>Introduction: </strong>Gait impairment in amyotrophic lateral sclerosis (ALS) substantially increases fall risk and accelerates functional decline. However, prospective data linking quantitative gait parameters to fall outcomes remain scarce. We aimed to identify gait parameters associated with falls and functional decline in ALS.</p><p><strong>Methods: </strong>In this single-center prospective cohort study, we enrolled 256 ALS patients and 256 matched healthy controls. Nineteen spatiotemporal gait parameters were captured using a 3D vision-based system at baseline. Falls, time to wheelchair use, and ALSFRS-R decline were recorded over 12 months. Multivariable logistic regression was used to identify independent fall predictors.</p><p><strong>Results: </strong>During follow-up, 129 of 224 patients (57.6%) experienced at least one fall. Prolonged Timed Up and Go (TUG) time (OR = 1.083 per second, 95% CI, 1.036-1.133, p < 0.001), younger age (OR = 0.968 per year, 95% CI, 0.940-0.996, p = 0.024), and lower MRC sum score (OR = 0.976 per point, 95% CI, 0.954-0.998, p = 0.035) independently predicted falls. The model showed moderate discrimination (AUC = 0.665, 95% CI, 0.594-0.736). Gait speed (r<sub>s</sub> = 0.366) and TUG time (r<sub>s</sub> = -0.381) correlated most strongly with time to wheelchair use (both p < 0.001), whereas no gait parameters correlated with ALSFRS-R decline rate.</p><p><strong>Conclusion: </strong>TUG time, younger age, and lower MRC score independently predict falls in ALS, though with modest predictive accuracy. The modest model performance underscores the multifactorial nature of falls and the need for multi-domain risk assessment. Gait speed and TUG time may warrant further investigation as candidate surrogate markers for functional decline. Future studies integrating cognitive evaluation, continuous monitoring, and attention to psychosocial factors may improve prediction and fall prevention strategies.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13695529/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149025562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Physical Training in Parkinson's Disease: A Systematic Review of Neurobiological Mechanisms, Brain-Muscle Adaptations, and Implications for Personalized Rehabilitation.","authors":"Anthony Jannou, Marie-Laure Welter","doi":"10.1159/ndd/aduag002","DOIUrl":"10.1159/ndd/aduag002","url":null,"abstract":"<p><strong>Background: </strong>Physical Training (PT), defined a planned, structured, and long-term exercise intervention, is recognized as an important non-pharmacological therapy in Parkinson's disease (PD). Beyond its symptomatic benefits, experimental evidence suggests that PT may also modulate pathological mechanisms involved in dopaminergic neurodegeneration. This systematic review summarizes the neurobiological and neurophysiological adaptations induced by PT in animal models of PD and in patients with PD, and proposes mechanistically driven recommendations for personalized exercise prescription.</p><p><strong>Summary: </strong>MEDLINE and Web of Science were searched from January 1, 1974, to April 3, 2026. The PRISMA 2020 guidelines were followed, and two reviewers independently screened titles and abstracts to identify studies that reporting neurobiological or neurophysiological effects of PT performed for at least 4 weeks, in both animal models of PD or in patients with PD. Risk of bias were assessed using validated tools for animal studies (SYRCLE), and for randomized (RoB 2) or non-randomized controlled trials (ROBINS-I) in humans. A total of 78 studies were included, comprising 55 animal studies and 23 studies in patients with PD. In parkinsonian animals, PT consisted mainly of forced treadmill training, performed 20-60 min/day, 5 days/week, typically for 4 weeks. PT reduced oxidative stress and mitochondrial dysfunction, enhanced antioxidant defences, and regulated mitochondrial dynamics. Exercise also decreased α-synuclein accumulation, attenuated neuroinflammation, and increased neurotrophic factor expression. These adaptations promoted synaptic plasticity, neurogenesis, and preservation of nigrostriatal dopaminergic neurons. In patients with PD, aerobic training (AT), resistance training (RT) and balance training (BT) have been tested, and multimodal interventions have been investigated, most commonly involving 120-150 min/week for 6-12 weeks, sometimes combined with virtual reality or exergaming. PT induced structural and functional adaptations across the brain-muscle axis, including modulation of dopaminergic signalling, reorganization of cortico-striatal and cerebellar connectivity, improved cortical inhibitory control, enhanced corticospinal drive, and neuromuscular remodelling. AT mainly improved fatigability and cardiorespiratory fitness, whereas RT and BT appear to preferentially enhance muscle strength, rate of force development, gait automaticity, and balance control.</p><p><strong>Key messages: </strong>Current evidence indicates that PT acts as a multimodal intervention capable of inducing adaptations ranging from molecular pathways to large-scale motor networks in PD. These findings support the implementation of personalized multimodal programmes combining AT, RT and BT, with progressive intensity and long-term adherence. Future studies should better define dose-response relationships, identify biomarkers of responsi","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148897530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Patrick Stancu, Anna E Goodheart, Lisa Hentsch, Caroline Hertler, Gilles Allali, Frédéric Assal
{"title":"When Walking Outlasts Cognition: Rethinking the Late-Stage of Lewy Body Dementia.","authors":"Patrick Stancu, Anna E Goodheart, Lisa Hentsch, Caroline Hertler, Gilles Allali, Frédéric Assal","doi":"10.1159/ndd/aduag001","DOIUrl":"10.1159/ndd/aduag001","url":null,"abstract":"<p><strong>Background: </strong>Lewy body dementia (LBD) is characterized by pervasive cognitive, motor, and neuropsychiatric symptoms. Although cognitive decline has traditionally shaped staging and prognosis, accumulating evidence indicates that gait and postural disturbances follow partially independent trajectories and may remain preserved even as cognition deteriorates. These observations challenge conventional assumptions about late-stage decline and suggest that locomotor function may complement cognitive measures when assessing late-stage transition in LBD.</p><p><strong>Summary: </strong>This review synthesizes current evidence on gait disturbances across the LBD spectrum and their neural substrates, in comparison with Alzheimer's disease (AD) and Parkinson's disease (PD). Gait impairment in LBD arises from distributed network dysfunction involving dopaminergic and cholinergic pathways, fronto-striatal, parietal, and cerebellar contributions, resulting in greater gait variability, reduced automaticity, and heightened dual-task costs relative to AD and PD. Despite this vulnerability, preserved procedural memory, brainstem locomotor circuits, and cerebellar-cortical compensation may allow walking to persist longer than cognition in some individuals. In advanced disease, rapid gait deterioration has been described near the end of life, suggesting that gait trajectories may capture aspects of late-stage decline that cognitive measures, affected by fluctuations and attentional instability, may not reliably reflect.</p><p><strong>Key messages: </strong>Gait and cognition do not decline in parallel in LBD; in some individuals, walking may outlast cognitive abilities. Gait disturbances reflect distributed network dysfunction rather than isolated motor system degeneration. In late stages, gait performance may offer a clinically useful indicator of disease transition when cognitive testing becomes less reliable. Integrating gait assessment into clinical evaluation may enhance prognostication and support palliative care planning in LBD.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1"},"PeriodicalIF":4.0,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13668057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148760812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tshibambe N Tshimbombu, Kyle E Thurmann, Boris Decourt, Arsene Daniel Nyalundja, Samira Braimah Shardow, Melissa Ewurakua Amoako, Gates Mulume Iragi, Josué Aganze Mwambali, Marwan N Sabbagh
{"title":"Autophagy in Alzheimer's Disease: Mechanisms, Clinical Trials, and Horizons.","authors":"Tshibambe N Tshimbombu, Kyle E Thurmann, Boris Decourt, Arsene Daniel Nyalundja, Samira Braimah Shardow, Melissa Ewurakua Amoako, Gates Mulume Iragi, Josué Aganze Mwambali, Marwan N Sabbagh","doi":"10.1159/000553506","DOIUrl":"10.1159/000553506","url":null,"abstract":"<p><strong>Background: </strong>Alzheimer's disease (AD) is an incurable progressive neurodegenerative disorder characterized by the pathological accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles in the brain. Recent findings have identified dysregulation of autophagy, a cellular mechanism for degradation and recycling, as a crucial contributor to the pathogenesis of AD. This narrative review examines the role of autophagy in the metabolism of Aβ and tau and evaluates current therapeutic strategies aimed at modulating autophagic pathways.</p><p><strong>Summary: </strong>Autophagy is governed by the key molecular regulators mammalian target of rapamycin, adenosine monophosphate-activated protein kinase, Beclin-1, and transcription factor EB, which collectively control the clearance of protein recycling, including aggregates, inside cells. Pharmacological agents such as rapamycin, resveratrol, and trehalose, alongside sigma-1 receptor agonists and gene therapy approaches, have demonstrated potential in modulating autophagy in preclinical and clinical studies. Despite these advances, significant challenges persist, namely, neuronal heterogeneity, optimal timing for therapeutic intervention, and the absence of reliable biomarkers to monitor autophagic activity and treatment efficacy.</p><p><strong>Key messages: </strong>Targeting autophagy offers a promising and potentially safe avenue for slowing AD progression. Future investigations should prioritize the development of selective autophagy modulators and personalized treatment strategies to restore autophagic flux and enhance clinical outcomes in patients with AD.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1-16"},"PeriodicalIF":4.0,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13493059/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148422925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mohammad Ali Rafiei, Sara Sadeghzadeh, Mehri Salari, Masoud Etemadifar
{"title":"Spinocerebellar Ataxia Type 12: Spectrums of Movement Disorders and Clinical Features.","authors":"Mohammad Ali Rafiei, Sara Sadeghzadeh, Mehri Salari, Masoud Etemadifar","doi":"10.1159/000553488","DOIUrl":"10.1159/000553488","url":null,"abstract":"<p><strong>Background: </strong>Spinocerebellar ataxia type 12 (SCA12) is a neurodegenerative disorder caused by a CAG repeat expansion in the PPP2R2B gene. It is characterized by tremor, cerebellar ataxia, and a wide range of neurological symptoms. The heterogeneity of SCA12 symptoms, particularly in movement presentation, highlights the need for standardized studies to better define its clinical spectrum.</p><p><strong>Summary: </strong>This review evaluates the spectrum of movement disorder symptoms, focusing on their type, age of onset, and progression, and highlights areas requiring further research. Tremor, typically action or postural, is often the initial symptom, followed by progressive cerebellar dysfunction, including gait instability, dysmetria, and dysdiadochokinesia, supported by neuroimaging evidence of cerebellar atrophy. Other movement-related features, such as dystonia and parkinsonism, further complicate the clinical picture. Psychiatric manifestations, including cognitive decline and depression, are also reported, though their prevalence varies. A clear characterization of the movement symptoms of SCA12 will guide future research into targeted therapeutic strategies, addressing the significant unmet needs of affected patients. This review underscores the importance of a multidisciplinary approach to studying SCA12, combining all relevant clinical data to advance knowledge and improve patient outcomes.</p><p><strong>Key messages: </strong>SCA12 presents predominantly with tremor, often preceding cerebellar signs by years. The clinical phenotype is broader than previously recognized, including dystonia, parkinsonism, and neuropsychiatric symptoms. Clinical variability may delay suspicion of SCA12, supporting early genetic testing. Systematic clinical characterization is critical for improving patient management.</p>","PeriodicalId":19115,"journal":{"name":"Neurodegenerative Diseases","volume":" ","pages":"1-12"},"PeriodicalIF":4.0,"publicationDate":"2026-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13461124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148422914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}